Element Biosciences
7 known investors
Element Biosciences develops biological analysis platforms and DNA sequencing tools for scientists and research institutions. The company serves a global customer base across 40+ countries in the life sciences and genomics industry.
Investors · 7
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$175M disclosed across 1 of 2 rounds · 2024–2026
- $175MSeries EJun 2026 · 5 sources
Samsung Electronics
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapCompanies competing with Element Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Acquisitions · 1
Early investors' stakes continue via these dealsLoop Genomics developed long-read sequencing technology that used synthetic long reads to enable full-length sequencing of DNA and RNA molecules on standard short-read sequencers. Acquired by Element Biosciences in 2021.
In the news
Frequently asked questions
- What does Element Biosciences do?
- Element Biosciences develops biological analysis platforms and DNA sequencing tools for scientists and research institutions. The company serves a global customer base across 40+ countries in the life sciences and genomics industry.
- Who are Element Biosciences's investors?
- Element Biosciences's investors include Draper Associates, Foresite Capital, Fusion, RA Capital, TSVC, Venrock.
- How much funding has Element Biosciences raised?
- Element Biosciences has disclosed $175M raised across 1 of its 2 known rounds.


